Sygnature Discovery, Proteros Biostructures collaborate

Friday, October 18, 2013

Sygnature Discovery, a provider of integrated drug discovery services, and Proteros, a biotechnology company in X-ray protein structure analysis, have entered a strategic alliance. Sygnature and Proteros will collaborate to provide integrated services to advance clients’ drug discovery projects. This new alliance adds an integral component to Sygnature’s “federated” CRO model.

[Read More]